Association of patisiran, an RNA interference therapeutic, with regional left ventricular myocardial strain in hereditary transthyretin amyloidosis: the APOLLO study - Minamisawa, Masatoshi; Kristen, Arnt (JAMA cardiology, 2019)
Gesehen am 21.08.2019